Fenofibrate in Combination With Ursodeoxycholic Acid in Primary Biliary Cholangitis: a Real World Study

PHASE3RecruitingINTERVENTIONAL

Enrollment

150

Participants

Timeline

Start Date

January 30, 2024

Primary Completion Date

December 31, 2035

Study Completion Date

December 31, 2035

Conditions

Primary Biliary Cholangitis (PBC)

Interventions

DRUG

Fenofibrate in Combination With Ursodeoxycholic Acid

Experimental: Fenofibrate 200 mg Capsules

Trial Locations (1)

RECRUITING

Xijing hospital, Xi'an

All Listed Sponsors

lead

Xijing Hospital of Digestive Diseases

OTHER